Barth, D; Stradner, M; Hutterer, H; Spiegelberg, J; Bauernhofer, T; Absenger, G; Jost, P; Pichler, M
Blood-based B-cell subtypes as predictors of treatment response during treatment with immune checkpoint inhibitors: a prospective longitudinal pan-cancer study.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology 2022. 2022; -OeGHO Frühjahrstagung 2022; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T
Thromboprophylaxis and its influence on the risk of thromboembolism in patients with germ cell tumors receiving cisplatin-containing chemotherapy
ONCOL RES TREAT. 2022; 45(SUPPL 2):322-322.
[Poster]
Web of Science
Bauernhofer, T;
Prostatakarzinom: gibt es eine personalisierte Medizin beim
metastasierten Prostatakarzinom?
OeGHO- & AHOP-Frühjahrstagung ; APR,8-10, 2021; Wien. 2021.
[Oral Communication]
FullText
Bauernhofer,T;
Diagnostik für die personalisierte Medizin des Prostatakarzinoms: Was, wo (Gewebe oder liquid biopsy) und wann?
https://us02web.zoom.us/j/86457520410. 2021; -Jahrestagung der Deutschen Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO); OCT 1-4, 2021; Berlin.
[Oral Communication]
Bauernhofer,T;
Diskutant Urogenitale Tumoren ASCO 2021
Best of ASCO 2021 Annual Meeting; JUN25-26, 2021; Wien. 2021.
[Oral Communication]
FullText
Georgios Vlachos, Sabrina Weber, Tina Moser, Kevin Lang, Paul Faschauner, Anna Eberhard, Jelena Belic, Isaac Lazzeri, Martin Pichler, Michael Speicher, Thomas Bauernhofer, Ellen Heitzer
Paired analysis of blood plasma and urine reveals complementary information in prostate cancer
Advances in circulating tumor cells ; SEP 22-25, 2021; Kalamata, GREECE. 2021.
[Poster]
FullText
Mischinger, HJ; Wagner, D; Bajric, T; Winkler, P; Stranzl-Lawatsch, H; Bergholf, A; Bauernhofer, T; Schemmer, P; Werkgartner, G; Kornprat, P
Intraoperative radiation therapy for pancreatic cancer - a prospective, randomised controlled trial
Special Issue of the European Journal of Surgical Oncology Nov 2021. 2021; -ESSO 40 - Meeting of the European Society for Surgical Oncology; NOV 8-10, 2021; Lissabon.
[Poster]
Andritsch, E; Farkas, C; Stanzer, S; Bauernhofer, T; Vigier, M
Psychoneuroimmunological predictors of breast cancer progression.
J PSYCHOSOM RES. 2020; 133: 110081-
Doi: 10.1016/j.jpsychores.2020.110081
Web of Science
FullText
FullText_MUG
Bauernhofer, T; Stanzer, S; Prietl, B; Kofler, S; Obermayer-Pietsch, B; Pichler, M; Sourij, H; Pieber, T
Tregs cells - a double edged sword? Lessons learned from colorectal cancer in comparison to type 1 diabetes mellitus.
ONCOL RES TREAT. 2020; 43(SUPPL 4):127-128.
[Poster]
Web of Science
Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E
Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.1331
[Onlinepräsentation]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Hofmann, L; Sallinger, K; Haudum, C; Smolle, M; Heitzer, E; Moser, T; Novy, M; Gesson, K; Kroneis, T; Bauernhofer, T; El-Heliebi, A
Improved sensitivity of liquid biopsies in prostate cancer: A multi-analyte approach.
EACR Liquid Biopsies Virtual Event; NOV 18-19, 2020; Nottingham, UK. 2020.
[Poster]
Hofmann, L; Sallinger, K; Haudum, C; Smolle, M; Heitzer, E; Moser, T; Novy, M; Gesson, K; Kroneis, T; Bauernhofer, T; El-Heliebi, A
Another step towards personalized medicine: A multi-analyte approach for improved sensitivity of liquid biopsies in prostate cancer.
4th Annual Meeting of the ÖPPM; Vienna, AUSTRIA. 2020.
[Poster]
Katja Sallinger; Lilli Hofmann;Thomas Kroneis; Thomas Bauernhofer; Ellen Heitzer; Amin El-Heliebi
Tracking the trace: Elucidating the source of
circulating tumor cells and circulating tumor
DNA.
4th Annual Meeting of the ÖPPM;; 2020; Vienna, AUSTRIA. 2020.
[Poster]
Klec, C; Schwarzenbacher, D; Gottschalk, B; Margit, R; Prinz, F; Bauernhofer, T; Stoeger, H; Graier, WF; Pichler, M
Deciphering the interplay between nuclear RNA export factors and long non-coding RNAs in breast cancer metabolism.
ANN ONCOL. ESMO Breast Cancer Virtual Meeting 2020. 2020; 31(S2):S38-S38.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.03.202
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Moser, T; Waldispuehl-Geigl, J; Belic, J; Perakis, S; Weber, S; Zhou, Q; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR
Early circulating tumor DNA dynamics as a real-time predictor of FOLFOX efficacy in advanced colorectal cancer patients
CANCER RES. 2020; 80(16):
Doi: 10.1158/1538-7445.AM2020-4295
[Poster]
Web of Science
FullText
FullText_MUG
Moser, T; Waldispuehl-Geigl, J; Belic, J; Weber, S; Zhou, Q; Hasenleithner, S; Graf, R; Terzic, JA; Posch, F; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR
Real-time measurements of circulating tumor DNA levels during FOLFOX treatment in patients with colorectal cancer.
4th Annual Meeting of the ÖPPM; Vienna, AUSTRIA. 2020.
[Poster]
Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A
Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress).
[Oral Communication]
Web of Science
Seles, M; Hutterer, GC; Foßelteder, J; Bauernhofer, T; Zigeuner, R; Pummer, K; Slaby, O; Pichler, M; Klec, C
Aufschlüsselung der onkogenen Funktionen der langen nicht-kodierende RNA "PANTR1" beim klarzelligen Nierenzellkarzinom.
72. Jahrestagung der Deutschen Gesellschaft für Urologie; Sept 23-26; Leipzig, Online. 2020.
[Onlinepräsentation]
Seles, M; Hutterer, GC; Foßelteder, J; Svoboda, M; Resel, M; Barth, DA; Pichler, R; Bauernhofer, T; Zigeuner, RE; Pummer, K; Slaby, O; Klec, C; Pichler, M
Aufschlüsselung der onkogenen Funktionen der langen nicht-kodierende RNA "PANTR1" beim klarzelligen Nierenzellkarzinom.
72. Kongress der Deutschen Gesellschaft für Urologie; Sep, 14-26 2020; Hamburg, Germany/Virtuell. 2020.
[Onlinepräsentation]
Bauernhofer, T
Nierenzellkarzinom 2019-Der Stellenwert der Monotherapie in der Sequenz-was sagen die Guidelines
18. Onkologische Wintergespräche; JAN 18-19, 2019; Salzburg. 2019.
[Oral Communication]
Hofmann, L; Atas, E; Kroneis, T; Bauernhofer, T; El-Heliebi, A
A liquid biopsy approach to detect potential predictive biomarkers in circulating tumor cells of prostate cancer patients
ÖPPM-Personalized Medicine: Expectations and Economic Aspects; OCT 14, 2019; Vienna, AUSTRIA. 2019.
[Poster]
Hofmann, L; Hille, C; Laxman, N; Svedlund, J; Kroneis, T; Shukun, C; Ahlford, A; von Amsberg, G; Alsdorf, W; König, F; de Kruijff, I; Riethdorf, S; Gorges, TM; Pantel, K; Haudum, C; Ercan, E; Bauernhofer, T; Nilsson, M; Sedlmayr, P; El-Heliebi, A
Visualization and quantification of splice variants in circulating tumor cells of prostate cancer patients
EACR-ESMO Joint Conference on Liquid Biopsies; May 15-17, 2019; Bergamo, ITALY. 2019.
[Poster]
FullText
Hofmann, L; Teppan, J; Kroneis, T; Bauernhofer, T; El-Heliebi, A
Detection of clinically relevant transcripts in circulating tumor cells of prostate cancer patients by in situ padlock probe technology
ACTC - Liquid Biopsy: Latest Advances and Future Challenges ; OCT 2-5, 2019; Corfu, GREECE. 2019.
[Poster]
FullText
Klec, C; Schwarzenbacher, D; Gottschalk, B; Resel, M; Prinz, F; Heitzer, E; Bauernhofer, T; Stöger, H; Graier, WF; Pichler, M
Paraspeckle-associated protein 1 (PAP1) controls breast cancer growth by regulating and interacting with the long non-coding RNA NEAT1
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung 2019; 11.-13.April; Linz, AUSTRIA.
[Poster]
Klec, C; Schwarzenbacher, D; Resel, M; Rinner, B; Haybaeck, J; Höfler, G; Jahn, SW; Bauernhofer, T; Stöger, H; Pichler, M
miR-1287-5p inhibits triple negative breast cancer growth by interacting with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung; 11.-13.April; Linz, AUSTRIA.
[Poster]
Klec, C; Schwarzenbacher, D; Resel, M; Rinner, B; Haybaeck, J; Höfler, G; Jahn, SW; Bauernhofer, T; Stöger, H; Pichler, M
miR-1287-5p inhibits triple negative breast cancer growth by interacting with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung 2019; 11.-13.April; Linz, AUSTRIA.
[Oral Communication]
Seles, M; Fillafer, F; Posch, F; Terzic, J; Pichler, M; Hutterer, GC; Zigeuner, R; Pummer, K; Bauernhofer, T.
Lymphopenia can help to predict response to targeted 1st-line therapy in patients with metastatic renal cell carcinoma.
Europ Urolog Supplements. 2019; -Prize Winner Session at 34th Annual Congress of the European Association of Urology.; MAR 15-19; Bracelona, SPAIN.
[Oral Communication]
Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T;
Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA.
[Poster]
Web of Science
FullText
Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, C; St. John, J; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher,M
Inference of tumor cell-specific transcription factor binding from cell-free DNA enables tumor subtype prediction
Circulating Nucleic Acids in Plasma and Serum (CNAPS); SEP 23-25, 2019; Jerusalem, Israel. 2019.
[Poster]
FullText
Belic, J; Graf, R; Bauernhofer, T; Cherkas, Y; Peter, U; Waldispuehl-Geigl, J; Perakis, S; Gormley, M; Patel, J; Li, WM; Geigl, JB; Smirnov, D; Heitzer, E; Gross, M; Speicher, MR
Analysis of circulating tumor DNA reveals genomic alterations in metastatic prostate cancer patients treated with abiraterone acetate plus prednisone or enzalutamide
CANCER RES. 2018; 78(13):-Annual Meeting of the American-Association-for-Cancer-Research (AACR); APR 14-18, 2018; Chicago, IL.
Doi: 10.1158/1538-7445.AM2018-2959
[Oral Communication]
Web of Science
FullText
FullText_MUG
El-Heliebi, A; Hille, C; Laxman, N; Svedlund, J; Haudum, C; Ercan, E; Kroneis, T; Chen, S; Smolle, M; Rossmann, C; Krzywkowski, T; Ahlford, A; Darai, E; von Amsberg, G; Alsdorf, W; König, F; Löhr, M; de Kruijff, I; Riethdorf, S; Gorges, TM; Pantel, K; Bauernhofer, T; Nilsson, M; Sedlmayr, P
Visualisation and quantification of AR-V7, AR-FL, PSA and KRAS point mutations in CTCs.
International Symposium on Minimal Residual Cancer; MAY 3-5, 2018; Montpellier, FRANCE. 2018.
[Oral Communication]
FullText
El-Heliebi, A; Hofmann, L; Teppan, J; Reiter, B; Haudum, C; Ercan, E; Smolle, M; Chen, S; Kroneis, T; Ahlford, A; Krzywkowski, T; Svedlund, J; Laxman, N; Darai, E; Dekruijff, I; Novy, M; Oberkanins, C; Gesson, K; Pühringer, H; Sedlmayr, P; Nilsson, M; Bauernhofer, T
A liquid biopsy approach to detect Androgen Receptor Variant 7 in prostate cancer
Österreichischen Plattform für Personalisierte Medizin (ÖPPM) ; OCT 11-12, 2018; Graz, AUSTRIA. 2018.
[Poster]
Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F
Estimated versus measured glomerular filtration rate to
evaluate kidney function in patients with cancer undergoing
cisplatin-based chemotherapy
Oncology Research
and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Poster]
Web of Science
FullText
Kroneis, T; Chen, S; Schmid, J; Ståhlberg, A; Sedlmayr P; Bauernhofer, T; El-Heliebi, A
Combining in vivo CTC enrichment devices with molecular downstream analysis
2nd Annual Meeting of the Austrian Platform for Personalized Medicine; OCT 11-12, 2018; Graz, AUSTRIA. 2018.
[Poster]
Seles, M; Fillafer, F; Posch, F; Pichler, M; Terzic, J; Mischinger, J; Hutterer, G; Zigeuner, R; Pummer, K; Bauernhofer, T
Lymphopenie als Prädiktor bei TKI-Erstlinientherapie des metastasierten klarzelligen Nierenzellkarzinoms
Der Urologe 2018, 57 (Suppl 1):S25/26.. 2018; -70. Kongress der Deutschen Gesellschaft für Urologie e.V.; 26.-29.09.2018; Messe Dresden, Deutschland.
[Oral Communication]
Seles, M; Fillafer, F; Posch, F; Terzic, J; Pichler, M; Hutterer, GC; Zigeuner, R; Pummer, K; Bauernhofer, T
Lymphopenia can help to predict response to targeted 1st-line therapy in patients with metastatic clear-cell renal cell carcinoma
Central European Meeting/European Association of Urology.; OCT 11-12,2018.; Cluj,ROMANIA.. 2018.
[Poster]
Seles, M; Fillhafer, F; Posch, F; Terzic, J; Pichler, M; Hutterer, G; Zigeuner, R; Pummer, K; Bauernhofer, T
Lymphopenie als Vorhersageparameter bei targeted Erstlinientherapie des metastasierten klarzelligen Nierenzellkarzinoms
German Medical Science GMS Publishing House;2018. Doc18urobay051. doi: 10.3205/18urobay051. 2018; -
44. Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie
; 14.-16.06.2018; Rosenheim, Deutschland.
[Oral Communication]
Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Pichler, M; Jahn, S; Stöger, H; Bauernhofer, T
Lymphopenia impairs response to 1st-line therapy with
sunitinib and pazopanib in patients with metastatic clear-cell
renal cell carcinoma.
Oncology Research
and Treatment . 2018; 41(Suppl4):42-43.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie,; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Oral Communication]
Web of Science
FullText
Viertler, C; Stadelmeyer, E; Jahn-Kuch, D; Al-Zoughbi, W; Pabst, D; Schauer, S; Fackelmann, U; Bitsche, S; Hofmann, G; Stöger, H; Bauernhofer, T; Gerger, A; Schüler, J; Zühlsdorf, M; Höfler, G
Case Report: Patient-derived xenograft model from multi-resistant prostate cancer.
Der Pathologe. 2018; 39(5):490-490.-Herbsttagung der ÖGPath/IAP Austria; SEP 27-28, 2018; Graz, AUSTRIA.
[Poster]
Zhou, Q; Perakis, S; Ulz, P; Pichler, M; Gerger, A; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR
Role of frequent chr13 q12.2 amplification in colorectal cancer patients
Role of frequent chr13 q12.2 amplification in colorectal cancer patients. 2018; -11th International Symposium on Minimal Residual Cancer; MAY 3-5, 2018; Montpellier, FRANCE.
[Poster]
Bauernhofer, T
Molecular subtypes and predictive markers
ONCOL RES TREAT. 2017; 40: 100-100.-Jahrestagung der DGHO, OeGHO, SGMO, SGH; SEP 29-OCT 3, 2017; Stuttgart, Germany.
[Oral Communication]
Web of Science
Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M
Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL.
Doi: 10.1200/JCO.2017.35.15_suppl.e16038
[Oral Communication]
Web of Science
FullText
FullText_MUG
El-Heliebi, A; Haudum, C; Ercan, E; Smolle, M; Chen, S; Kroneis, T Ahlford, A; Krzywkowski, T; Svedlund, J; Laxman, N; Darai, E; de Kruijff, I; Gorges, T; Hille, C; Pantel, K; Rossmann, C; Nilsson, M; Bauernhofer, T; Sedlmayr, P
A liquid biopsy to detect Androgen Receptor Variant 7 in prostate cancer
EACR Conference on Cancer Genomics; JUN 25-28,2016; Cambridge, United Kingdom. 2017.
[Poster]
El-Heliebi, A; Svedlund, J; Laxman, N; Hille, C; Haudum, C; Ercan, E; Chen, S; Kroneis, T; Ahlford, A; Krzywkowski, T; Darai, E; Smolle, M; de Kruijff, I; Pantel, K; Rossmann, C; Gorges, T; Bauernhofer, T; Nilsson, M; Sedlmayr, P
Early detection of therapy resistance in castration resistant prostate cancer patients
Personalized Medicine Platform Austria; OCT 19-20, 2017; Vienna, Austria. 2017.
[Poster]
El-Heliebi, A; Svedlund, J; Laxman, N; Hille, C; Haudum, C; Ercan, E; Chen, S; Kroneis, T; Ahlford, A; Krzywkowski, T; Darai, E; Smolle, M; de Kruijff, I; Pantel, K; Rossmann, C; Gorges, T; Bauernhofer, T; Nilsson, M; Sedlmayr; P
Detection of androgen receptor variant 7 (AR-V7) in prostate cancer CTCs using padlock probes
3rd Advances in Circulating Tumor Cells (ACTC): Liquid Biopsy in Clinical Practice; OCT 4-8; Ixia, Rhodos, GREECE . 2017.
[Poster]
Jelena Belic, Peter Ulz, Ellen Heitzer, Maria Smolle, Thomas Bauernhofer, Katja Fischereder, Jochen B. Geigl1, Michael R. Speicher
Detection and characterization of neuroendocrine prostate cancer using whole genome-sequencing in circulating tumor DNA
3rd EACR Conference on Cancer Genomics; Jun 25-28, 2017; Cambridge, UK. 2017.
[Oral Communication]
FullText
Martin Pichler, Daniela Schwarzenbacher, Verena Stiegelbauer, Gabriel Rinnerthaler, Thomas Bauernhofer, Gerald Höfler, Herbert Stöger
MicroRNA-1200s inhibits cellular growth of breast cancer through downregulating of PI3K signaling.
ÖGHO Frühjahrstagung; 2017.
[Poster]
Partl R, Bezan A, Posch F, Zurl B, Bauernhofer T, Pichler M, Szkandera J, Hutterer G, Pummer K, Kapp KS, Stöger H, Gerger A, Stotz M
Untersuchung von Risikofaktoren für die Entwicklung einer febrilen Neutropenie nach cisplatinhältiger Chemotherapie bei Patienten mit testikulären Keimzelltumoren.
Konferenzsband. 2017; -34. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik; OCT 5-6; Linz, AUSTRIA.
[Oral Communication]
Schmidinger, M; Pichler, R; Bauernhofer, T; Kretz, M; Tinchon, C; Niedersuss-Beke, D; Pfleger, G; Heinrich, E; Vogl, U; Mitterberger, M; Stoger, H; Tulchiner, G; Kratochvill, F; Mraz, B; Marszalek, M
Real-world evidence data on aRCC treatment in Austria: the RELACS study
ONCOL RES TREAT. 2017; 40: 276-276.-Jahrestagung der DGHO, OeGHO, SGMO, SGH; SEP 29-OCT 3, 2017; Stuttgart, Germany.
[Oral Communication]
Web of Science
Viertler, C; Stadelmeyer, E; Jahn-Kuch, D; Al-Zoughbi, W; Kashofer, K; Schauer, S; Fackelmann, U; Bitsche, S; Hofmann, G; Stöger, H; Bauernhofer, T; Schüler, J; Zühlsdorf, M; Höfler, G
Establishment of multi-resistant autopsy derived xenograft models representing progressive disease in cancer.
Der Pathologe. 2017; 38(5):487-487.-Herbsttagung der ÖGPath/IAP Austria; Sep 14-16, 2017; Velden am Wörthersee, AUSTRIA.
[Poster]
Viertler, C; Stadelmeyer, E; Jahn-Kuch, D; Al-Zoughbi, W; Kashofer, K; Schauer, S; Fackelmann, U; Thüringer, A; Bitsche, S; Hofmann, G; Stöger, H; Bauernhofer, T; Schüler, J; Zühlsdorf, M; Höfler, G
MR-PDX models for the evaluation of cancer therapies
CBmed Biomarker Conference; FEB 13, 2017; Graz, AUSTRIA. 2017.
[Poster]
Belic, J; Heitzer, E; Ulz, P; Auer, M; Fischereder, K; Bauernhofer, T; Geigl, JB; Speicher, MR
Analysis of ctDNA using the mFastSeqS and plasma-Seq methods for screening and therapy monitoring in prostate cancer patients
CLIN CANCER RES. 2016; 22: -Meeting of the American-Association-for-Cancer-Research (AACR) Precision Medicine Series - Integrating Clinical Genomics and Cancer Therapy; JUN 13-16, 2015; Salt Lake, UT.
Doi: 10.1158/1557-3265.PMSCLINGEN15-PR05
[Oral Communication]
Web of Science
FullText
FullText_MUG
Belic,J;Ulz,P; Graf, R; Auer, M; Fischereder, K; Hoefler, G;
Bauernhofer, T, Geigl, JB; Heitzer, E; Speicher, MR
Whole-genome sequencing of circulating tumor DNA reveals
relevance of focal amplifications for the management of
metastatic prostate cancer
Proceedings Book of the 24EACR. 2016; -EACR; JUL 9-12, 2016; Manchester, UK.
[Poster]
FullText
Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
ÖGHO; March 17-19, 2016; Wien. 2016.
[Oral Communication]
Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Gerger, A; Stotz, M;
23 Risk stratification for venous thromboembolism in patients with testicular germ cell tumours
European Urology Supplements. 2016; 15(3):E23--European Association of Urology (EAU) Annual Meeting; MAR 11-15, 2016; Munich, GERMANY.
[Oral Communication]
FullText
De Santis, M; Bauernhofer,T; Stoiber, F; Höltl, L; Sommerhuber, A; Klocker, J; Meran, JG; Kilkovich,J; Colleseli, D; Dietrich, C; Pantel, K; Riethdorf, S;
Circulating tumor cells (CTC) and Her-2 status on CTC and primary tumor in urothelial cancer (UC) patients refractory to platinum based chemotherapy.
Journal of Clinical Oncology. 2016; 34:(4s,):abstr.-4520.-ASCO Annual Meeting; JUN 3-7, 2016; Chicago, IL, USA.
[Poster]
El-Heliebi, A; Haudum, C; Chen, S; Kroneis, T; Ercan, E; Fuchs, J; Bauernhofer, T; Nilsson, M; Ahlford, A; Svedlund, J; Krzywkowski, T; Sedlmayr, P
Adding more Information to Circulating Tumor Cells - In Situ Detection and Visualisation of Androgen Receptor Splice Variants in Prostate Cancer Cells
3rd Austrian Biomarker Symposium 2016
; MAR 10-11, 2016; Vienna, AUSTRIA. 2016.
[Poster]
El-Heliebi, A; Haudum, C; Chen, S; Kroneis, T; Ercan, E; Fuchs, J; Bauernhofer, T; Nilsson, M; Ahlford, A; Svedlund, J; Krzywkowski, T; Sedlmayr, P
In vivo isolation of circulating tumor cells and in situ detection of androgen receptor splice variants
3rd Austrian Biomarker Symposium 2016; MAR 10-11, 2016; Vienna, AUSTRIA. 2016.
[Oral Communication]
Heitzer, E; Perakis, S; Auer, M; Belic, J; Ulz, P; Lafer, I; Bauernhofer, T; Petru, E; Augustin, H; Geigl, JB; Speicher, MR.
Clinical Utility of Circulating Tumor DNA Monitoring: A report of more than 400 plasma-Seqs
Medizinische Genetik. 2016; -GfH Tagung ; MAR 16-18, 2016; Lübeck, GERMANY.
[Oral Communication]
Jelena Belic, Peter Ulz, Ellen Heitzer, Martina Auer, Katja Fischereder, Thomas Bauernhofer, Jochen B. Geigl, Michael R. Speicher
Detection of clonal shifts in metastatic prostate cancer patients using whole genome-sequencing in circulating tumor DNA
10th ISMRC International Symposium on Minimal Residual Cancer:
Liquid Biopsy in Cancer Diagnostics and Treatment
; März 19-21, 2016; Hamburg, GERMANY. 2016.
[Oral Communication]
Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M
Stromel co-expression of urokinase-type plasminogen activator (uPA) and plasminogen activator Inhibitor (PAI-1) protein by IHC predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer
CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS15-P2-08-21
[Poster]
Web of Science
FullText
FullText_MUG
Smolle, MA; Pichler, M; Roßmann, C; Samonigg, H; Heitzer, E; Belic, J; Speicher, M; Pummer, K; Bauernhofer, T
Neuroendocrine transdifferentiation in castration resistant metastatic prostate cancer (mCRPC) - A case series
OeGHO & AHOP Frühjahrstagung; MAR 17 - 19, 2016; Vienna, AUSTRIA. 2016.
[Poster]
Ulz, P; Belic, J; Graf, R; Auer, M; Lafer, I; Fischereder, K; Webersinke, G; Pummer, K; Augustin, H; Pichler, M; Hoefler, G; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR;
Whole-genome plasma sequencing reveals focal amplifications as driving force in metastatic prostate cancer
16. Jahrestagung der Österreichischen Gesellschaft für Humangenetik; SEP 30, 2016; Vienna, AUSTRIA. 2016.
[Oral Communication]
Viertler, C; Stadelmeyer, E; Al-Zoughbi, W; Kashofer, K; Schauer, S; Fackelmann, U; Bauernhofer, T; Samonigg, H; Jahn-Kuch, D; Schüler, J; Zühlsdorf, M; Höfler, G
MR-PDX models for the evaluation of cancer therapies
CBmed Biomarker Conference; FEB 11, 2016; Graz, AUSTRIA. 2016.
[Poster]
Zhou, Q; Perakis, S; Ulz, P; Heitzer, E; Pichler,M; Gerger, A; Bauernhofer, T; Geigl, JB; Speicher, MR
Monitoring targeted therapy response by cell-free circulating tumor DNA in metastatic colorectal cancer
Doctoral day; DEC 14, 2016; Graz, Austria. 2016.
[Poster]
Aigner, B; Bauernhofer, T; Petru, E; Niederkorn, A; Arzberger, E; Aschauer, M; Richtig, E
Vollständige Abheilung einer ausgeprägten Lokalreaktion durch
die Verabreichung von Dexrazoxan 72 Stunden nach Epirubicin
Extravasation
ÖGDV Jahrestagung 2015; Dez 4-6, 2015; Wien. 2015.
[Poster]
Belic, J; Heitzer, E; Ulz, P ; Auer, M; Fischereder, K; Bauernhofer, T; Geigl, JB; Speicher, MR
Analysis of ctDNA using mFastSeqS and plasma–Seq methods for screening and therapy monitoring in prostate cancer patients
AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy; June 13-16, 2015; Salt Lake City, Utah, USA. 2015.
[Oral Communication]
FullText
Belic, J; Koch, M; Ulz, P; Auer, M; Fischereder, K; Bauernhofer, T; Geigl, JB; Speicher, MR Heitzer, E
Modified FAST-SeqS approach as a pre-screening method for detection of plasma samples with elevated ctDNA in prostate cancer patients
EACR CONFERENCE SERIES 2015
2ND SPECIAL CONFERENCE: CANCER GENOMICS; 28 JUNE – 1 JULY 2015; Cambridge, UK. 2015.
[Poster]
FullText
Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer E.
mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-specific Aneuploidy in Plasma DNA
Circulating Nucleic Acids in Plasma and Serum - Proceedings. 2015; -CNAPS; SEP 10-12, 2015; Berlin, GERMANY.
[Oral Communication]
Heitzer, E; Ulz, P; Auer, M; Belic, J; Sumitra, M; Lax, S; Hoefler, G; Augustin, H; Edgar, P; Bauernhofer, T; Geigl, J; Speicher, M
Clinical utility of circulating tumor DNA in human cancers: A report of more than 300 plama-Seqs
EUR J CANCER. 2015; 51: S33-S33.-European Cancer Congress; Sep 25-29, 2015; Vienna, AUSTRIA.
Doi: 10.1016/S0959-8049(16)30108-3
[Poster]
Web of Science
FullText
FullText_MUG
J. Belic, M. Koch, P. Ulz, M. Auer, K. Fischereder, T. Bauernhofer, J. B. Geigl, M. R. Speicher, E. Heitzer
Modified FAST-SeqS approach as a pre-screening method for detection of plasma samples with elevated ctDNA in prostate cancer patients
2nd EACR Special Conference on Cancer Genomics, Churchill College; June-July 28-1, 2015; Cambridge, UK. 2015.
[Poster]
Kammerer, S; Jahn, S; Winter, E; Sokolowski, A; Hackl, H; Platzer, D; Peintinger, F; Schreibmayer, W; Bauernhofer, T
GIRK1: a new prognostic biomarker for estrogen receptor positive breast cancer
OeGHO Frühjahrstagung 2015; APR 23-25, 2015; Salzburg, AUSTRIA. 2015.
[Poster]
Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, SW; Peintinger, F; Symmans, F; Schreibmayer, W; Bauernhofer, T.
GIRK1 overexpression correlates with ER positive breast cancer subtypes and is associated with poor prognosis.
Annals of Oncology 2015;26(Supplement 3):15-24. 2015; 26(Supplement 3): 22--IMPAKT 2015 Breast Cancer Meeting; MAY 7-9, 2015; Brussels, BELGIUM.
[Poster]
Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M
Influence of immunohistological detection of intratumoral urokinase-type plasminogen activator (uPA) on disease outcome in endocrine-treated postmenopausal patients with hormone receptor-positive early breast cancer.
J CLIN ONCOL. 2015; 33(15):
Doi: 10.1200/jco.2015.33.15_suppl.551
[Poster]
Web of Science
FullText
FullText_MUG
Ulz, P; Auer, M; Belic, J; Lafer I; Jahn, SW; Pristauz, G; Heidary, M; Schwarzbraun, T; Fischereder K; Gerger, A; Hoefler; G; Augustin, H; Bauernhofer, T; Petru, E; Heitzer, E; Geigl, JB; Speicher, MR
Circulating tumor DNA sequencing reveals cancer driver genes and their plasticity
in focal amplifications
Medizinische Genetik. 2015; 27(1):79-109.-26. Jahrestagung der Deutschen Gesellschaft für Humangenetik gemeinsam mit der Österreichischen Gesellschaft für Humangenetik und der Schweizerischen Gesellschaft für Medizinische Genetik; APR 15-17, 2015; Graz, AUSTRIA.
[Oral Communication]
FullText
Ulz, P; Heitzer, E; Belic, J; Lafer, I; Schwarzbraun, T; Bauernhofer, T; Eisner, F; Pichler, M; Fischereder, K; Gutschi, S; Augustin H; Pummer K; Webersinke, G; Geigl, JB; Speicher, MR;
Whole-genome plasma sequencing reveals focal amplifications as driving force in metastatic prostate cancer
15. Jahrestagung der Österreichischen Gesellschaft für Humangenetik; SEP 25, 2015; Salzburg, AUSTRIA. 2015.
[Oral Communication]
Viertler, C; Bauernhofer, T; Höfler, G
ADX-models for the evaluation of cancer treatments.
CBmed Kick-off Meeting; JAN 22, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Eisner, F; Suppan, C; Kasparek, AK; Samonigg, H; Höfler, G; Zigeuner, R; Bauernhofer, T
Partielle Remission unter Therapie mit Everolimus bei 51jähriger Patientin mit Lymphangioleiomyomatose.
ÖGHO Frühjahrstagung ; APR 10-12, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Heitzer, E; Mohan, S; Ulz, P; Lafer, I; Auer, M; Lax, S; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR;
Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
EUR J CANCER. 2014; 50: S96-S96.-EACR 2014; München.
Doi: 10.1016/S0959-8049(14)50357-7
[Poster]
Web of Science
FullText
FullText_MUG
Kammerer, S; Sokolowski, A; Hackl, H; Jahn, S; Asslaber, M; Symmans, F; Peintinger, F; Regitnig, P; Schreibmayer, W; Bauernhofer, T
OVEREXPRESSION OF G PROTEIN-ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL 1 (GIRK1) IS ASSOCIATED WITH LYMPH NODE METASTASIS AND POOR PROGNOSIS IN BREAST CANCER
ANN ONCOL. . 2014; 25: -IMPAKT Breast Cancer Conference; MAY 08-10, 2014; Brussels, BELGIUM.
Doi: 10.1093/annonc/mdu066.21
[Poster]
Web of Science
FullText
FullText_MUG
Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, S; Asslaber, M; Schreibmayer, W; Bauernhofer, T
Overexpression of GIRK1 is associated with lymph node metastasis and poor prognosis in breast cancer.
ZMF 10th Anniversary - Scientific Symposium.; JUL 17-18, 2014; Graz, AUSTRIA. 2014.
[Oral Communication]
Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, S; Schreibmayer, W; Bauernhofer, T
GIRK1 overexpression correlates with ER positive breast cancer subtypes and is associated with poor prognosis.
Doctoral Day 2014; DEC 10, 2014; Graz, AUSTRIA. 2014.
[Poster]
Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, S; Schreibmayer, W; Bauernhofer, T
G protein-activated inward rectifier potassium channel 1 overexpression is associated with lymph node metastasis and poor prognosis in breast cancer.
ÖGMBT 6th Annual Meeting; SEPT 15-18, 2014; Vienna, AUSTRIA. 2014.
[Oral Communication]
Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Rezania, S; Jahn, S; Asslaber, M; Regitnig, P; Schreibmayer, W; Bauernhofer, T
G protein-activated inward rectifier potassium channel 1 (GIRK1) expression in breast cancer.
Gordon Research Conference; JUN 8-13, 2014; Lucca (Barga), ITALY. 2014.
[Poster]
Li, CY; Rezania, S; Kammerer, S; Gorischek, A; Bauernhofer, T; Schreibmayer, W
Mechano-Sensitive Ion Channels (MSCS) Provide Human Breast Cancer Cells with a Sensorium for Mechanical Stress.
BIOPHYS J. 2014; 106(2):549A-550A.-58th Annual Meeting of the Biophysical-Society; FEB 15-19, 2014; San Francisco, CA.
Doi: 10.1016/j.bpj.2013.11.3061
[Poster]
Web of Science
FullText
FullText_MUG
Rezania, S; Li, CY; Kammerer, S; Gorischek, A; Devaney, T; Zarnani, AH; Bauernhofer, T; Schreibmayer, W;
G-Protein Activated Inwardly Rectifying Potassium Channels Control Motility of Breast Cancer Cells.
BIOPHYS J. 2014; 106(2):543A-543A.-58th Annual Meeting of the Biophysical-Society; FEB 15-19, 2014; San Francisco, CA.
Doi: 10.1016/j.bpj.2013.11.3026
[Poster]
Web of Science
FullText
FullText_MUG
Suppan, C; Bauernhofer, T; Eisner, F; Stöger, H; Balic, M; Schöllnast, H; Liegl-Atzwanger, B;
Efficacy of sorafenib in a patient with metastatic high grade thymic carcinoma
ÖGHO Frühjahrstagung; APR 10-12, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Suppan, C; Steger, G; Balic, M; Dandachi, N; Lang, A; Mlineritsch, B; Fesl,C; Samonigg, H; Gnat,M; Bauernhofer,T;
Evaluation of soluble E-Cadherin as a predictive marker for response to preoperative systemic chemotherapy in early breast cancer
Annals of Oncology Supplement 2014. 2014; -IMPAKT; May 7-10, 2014; Brussels, Belgium.
[Poster]
Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, A; Koller, K; Kiesslich, T; Schauer, S; Bauernhofer, T; Pichler, M;
Reduced Expression of the Putative Tumour Suppressor Spinophilin Is an Adverse Prognostic Factor in Squamous Cell Carcinoma of the Head and Neck.
MODERN PATHOL. . 2013; 26(S2):301A-301A.-102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); MAR 02-08, 2013; Baltimore, MD.
[Poster]
Web of Science
Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, A; Koller, K; Kiesslich, T; Schauer, S; Bauernhofer, T; Pichler, M
Reduced Expression of the Putative Tumour Suppressor Spinophilin Is an Adverse Prognostic Factor in Squamous Cell Carcinoma of the Head and Neck.
LAB INVEST. . 2013; 93(S1):301A-301A.-102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); MAR 02-08, 2013; Baltimore, MD.
[Poster]
Web of Science
Andritsch, E; Farkas, C; Zloklikovits,S; Samonigg, H;Bauernhofer,T
Hope and Optimism - The Additional Benefit for Patients With Cancer in the Interdisciplinary Treatment - From the Perspective of Psychoneuroimmunology.
PSYCHO-ONCOL. 2013; 22: 175-176.-15th World Congress of Psychooncology, Innovation in Psychooncology, clinical care- research-advocacy; NOV 4-8, 2013; Rotterdam, Netherlands.
[Poster]
Web of Science
Bauernhofer, T
Is there an overall survival benefit with regard to additional treatment options in the sequential therapy of patients with metastatic renal cell cancer?
ONKOLOGIE. 2013; 36: 202-202.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; Oct 18-22, 2013; Wien.
[Oral Communication]
Web of Science
Kammerer, S; Sokolowski, A; Rezania, S; Gorischek, A; Hackl, H; Malle, E; Jahn, S; Asslaber, M; Schreibmayer, W; Bauernhofer, T
GIRK1 protein expression in primary tumours of breast cancer patients.
Doctoral Day 2013; DEC 9, 2013; Graz, AUSTRIA. 2013.
[Poster]
Li, C; Rezania,S;, Kammerer, S; Gorischek, A; Bauernhofer, T; Schreibmayer, W;
Mechano-sensitive ion channels (MSCs) provide human breast cancer cells with a sensorium for mechanical stress
Doctoral Day 2013; Dec 9, 2013; Graz. 2013.
[Poster]
Mohan, S; Heitzer,E; Ulz, P; Lafer, I; Lax, S; Auer, M; Pichler,M; Eisner,F; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR;
Development of acquired resistance to anti-EGFR therapy in colorectal cancer identified by whole-genome plasma DNA sequencing
Doctoral Day; Dec 9, 2013; Graz. 2013.
[Poster]
Ress, AL; Aigelsreiter, A; Schauer, S; Eisner, F; Samonigg, H; Lackner, C; Haybaeck, J; Bauernhofer, T; Pichler, M
Correlation of loss of spinophilin expression with increased proliferation and viability as a prognostic factor in patients with hepatocellular carcinoma.
2013 ASCO Annual Meeting; Mai 31- Juni 4, 2013; Chicago. 2013.
Sauseng, S; Niernberger, T; Gabor, S; Mathew, E; Bauernhofer, T; Rabl, H;
R0 - Resektionen bei primär inoperablen Pankreastumoren nach neoadjuvanter FOLFIRINOX Therapie
54th Annual Meeting Of the Austrian Society of Surgery. 2013; 45(2):-Österreichischer Chirurgenkongress; MAI 30 - JUN 1, 2013; Vienna, Austria.
[Poster]
Heitzer, E; Auer, M; Hoffmann, EM; Beneken, C; Pichler, M; Lax, S; Ulz, P; Waldispuehl-Geigl, J; Mauermann, O; Lackner, C; Höfler, G; Eisner, F; Sill, H; Pantel, K; Riethdorf, S; Bauernhofer, T; Geigl, JB; Speicher, MR
Complex tumor genomes inferred from plasma-DNA and circulating tumor cells of patients with colorectal cancer.
Human Genetics Conference 2012; JUNE 23 - 27; Nürnberg, GERMANY. 2012.
[Oral Communication]
FullText
Li, C, Rezania, S, Gorischek, A, Bauernhofer, T, Schreibmayer, W
Electrophysiological Characterization of K+ channels in different breast cancer cell lines
the 4th ÖGMBT Annual Meeting; 17 to 19 September, 2012; Graz, AUSTRIA. 2012.
[Poster]
Li, C, Rezania, S,Gorischek, A, Bauernhofer, T, Schreibmayer, W
Electrophysiological Characterization of K+ channels in different breast cancer cell lines
Doctoral Day; 7 December, 2012; Graz, AUSTRIA. 2012.
[Poster]
Maritschnegg, E; Dandachi, N; Stadelmeyer, E;, Speicher, MR; Heitzer, E; Samonigg, H; Höfler, G; Pichler, M; Otte, M; Bauernhofer, T;
Blood-based treatment monitoring of metastatic colorectal
cancer patients by KRAS mutation analysis
Frühjahrstagung der österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 12-14, 2012; Graz. 2012.
[Poster]
Maritschnegg, E; Dandachi, N; Stadelmeyer, E;, Speicher, MR; Heitzer, E; Samonigg, H; Höfler, G; Pichler, M; Otte, M; Bauernhofer, T;
KRAS mutation analysis using blood derived cell free tumor DNA for treatment monitoring of metastatic colorectal cancer patients
Cancer Res., . 2012; 72: 4513. : -AACR Annual Meeting; MAR 31- APR 4, 2012; Chicago, USA.
[Poster]
Mohan, S; Auer, M; Heitzer, E; Pichler, M; Geigl, J; Höfler, G; Lax, S; Bauernhofer, T; Riethdorf, S; Pantel, K; Geigl, JB; Speicher, MR.
Analysis of Circulating Cell Free Tumor DNA in Plasma in Colon Cancer Patients.
Doctoral day; DEZ 7; Graz, AUSTRIA. 2012.
[Poster]
Pichler, M; Doleschal, B; Groschner, K; Maechler, H; Bauernhofer, T; Kass, D; Pieske, B; von Lewinski, D; Samonigg, H; Rainer, P
Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes
Frühjahrstagung der Österreichischen Gesellschaft für Hämatolologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Pichler, M; Winter, E; Bauernhofer, T; Lax, S; Samonigg, H; Hoefler, G
Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Rezania,S; Li,C; Gorischek, A; DeVaney, T; Zarnani, A; Bauernhofer, T; Schreibmayer, W
G-Protein activated inwardly rectifying potassium channel and cancer biology: Breast cancer as a model
Doctoral Day; DEZ 7, 2012; Graz. 2012.
[Poster]
Rezania,S; Li,C; Gorischek,A; Devaney,T; Bauernhofer,T; Schreibmayer,W
Influence of G-protein activated inwardly rectifying potassium channel on vital parameter of breast cancer cells
4th ÖGMBT Annual Meeting 2012; Sept 18 2012; Graz. 2012.
[Poster]
Tinchon, C; Hubmann, E; Pichler, M; Rabl, H; Uggowitzer, M; Jilek, K; Leitner,G; Bauernhofer,T;
Neoadjuvant FOLFIRINOX in pancreatic cancer:
a series of 11 patients
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz. 2012.
[Poster]
Eichmann, E; Eisner, F; Stojakovic, T; Kiesslich, T; Lackner, C; Bauernhofer, T; Mischinger, H; Samonigg, H; Pichler, M
Prognostic value of commonly measured laboratory parameters in
patients with biliary malignancies.
EUROPEAN SURGERY Acta Chirurgica Austriaca . 2011; -52. Österreichischer Chirurgenkongress; JUN 23-25, 2011; Vienna, AUSTRIA.
[Poster]
Li, C, Rezania, S, Gorischek, A, Bauernhofer, T, Schreibmayer, W
Biophysical characterization of G-protein Activated Inwardly Rectifying K+ channel in breast cancer cells
Doctoral Day; Nov. 4th, 2011; Graz, AUSTRIA. 2011.
[Poster]
Li C., Rezania S., Gorischek A., Bauernhofer T, Schreibmayer W.
Biophysical characterization of G-protein Activated Inwardly Rectifying K+ channel in breast cancer cells
Doctoral Day; December 7th, 2012; Graz, AUSTRIA. 2011.
[Poster]
Loibner, H; Poglitsch, M; Schwager, C; Stranner, S; Janzek ,E; Schuster, M; Bauernhofer, T; Samonigg, H
Cancer and the renin angiotensin system (RAS): Substantial activation as evidenced by quantification of various RAS peptides and their metabolites in plasma by LC-MS
J Clin Oncol 29; supp ( abstr e21171)
2011; -ASCO Annual Meeting; JUN 3-7, 2011; Chicago, IL, USA.
FullText
Rezania,S; Chouyang,L; Gorischek,A; Devaney,T; Regitnig,P; Bauernhofer,T; Schreibmayer,W;
Influence of G-protein activated inwardly rectifying potassium channel on
vital parameters of breast cancer cells
Doctoral Day; 4.11.2011; 2011.
[Poster]
Harbaum, L; Pollheimer, MJ; Bauernhofer, T; Kornprat, P; Lindtner, RA; Schlemmer, A; Rehak, P; Langner, C
Prolactin Receptor Expression in Colorectal Cancer Therapeutic Option for Affected Patients?
Ann Oncol 2010; 21, Supplement 1: i 30-i 30.-European Multidisciplinary Colorectal Cancer Congress; Mar 28-30, 2010; Nice, France.
[Poster]
Web of Science
Harbaum, L; Pollheimer, MJ; Bauernhofer, T; Kornprat, P; Lindtner, RA; Schlemmer, A; Rehak, P; Langner, C
The Cytokine Receptor Superfamily Serves as a Promising Therapeutic Target in Colorectal Cancer Which Prospects Arise from the Prolactin Receptor?
Abstractbook 2010; 33-34.-Pannonia Congress of Pathology / Spring Congress of the Austrian, Croatian, Hungarian and Slovenian Societies of Pathology and IAP Divisions; MAR 3-6, 2010; Graz, Austria.
[Poster]
Harbaum, L; Pollheimer, MJ; Bauernhofer, T; Kornprat, P; Lindtner, RA; Schlemmer, A; Rehak, P; Langner, C
Prolactin Receptor Expression in Colorectal Cancer Therapeutic Option for Affected Patients?
Onkologie 2010; 33, Supplement 2: 63-63.-29. Deutscher Krebskongress; FEB 24-27, 2010; Berlin, Germany.
[Oral Communication]
Web of Science
Müller, H; Sauer, S; Zatloukal, K; Bauernhofer, T
Interactive Patient Records.
Proceedings of IV'10 - 14th International Conference on Information Visualization, London, England, 20102010; 252-257.-14th International Conference on Information Visualization IV10; JUL, 27-29, 2010; London, UK. (ISBN: 978-1-4244-7846-0 )
[Oral Communication]
FullText
Osprian, I; Pichler, M; Samonigg, H; Ploner, F; Bauernhofer, T;
Third line treatment of relapsed small-cell lung cancer with irinotecan and carboplatin: A case report.
ÖGHO Frühjahrstagung 2010; APRIL 8-10, 2010; Bregenz, Austria. 2010.
[Poster]
Rühlinger, D; Szkandera, J; Pichler, M; Eisner, F; Stöger, H; Bauernhofer, T;
Sorafinib as forth-line treatment in a patient with metastatic gastrointestinal stromal tumour: a case report.
MEMO Suppl 01/10; 2010; 20-20.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10, 2010; Bregenz, AUSTRIA.
[Poster]
Szkandera, J; Ploner, F; Bauernhofer, T; Kasparek, AK; Payer, F; Balic, M; Knechtel, G; Gerger, A; Galle; Samonigg, H; Hofmann, g;
Paraneoplastic limbic encephalitis in a patient with extragonadal chorioncarcinoma - the significance of onconeural antibodies: a case report
MEMO Suppl 01/10; 2010; 20-21.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10; Bregenz, AUSTRIA .
[Poster]
Zloklikovits, S; Augustin, T; Stanzer, S; Samonigg, H; Bauernhofer, T; Andritsch, E
Psychoeducational group intervention in patients with early breast cancer: is there a waiting group effect?
Psycho-Oncology 2010; 19(Sup2):S281--12th IPOS World Congress of Psycho-Oncology; MAY 25-29, 2010; Quebec City, CANADA.
[Poster]
Bauernhofer, T; Dandachi, N; Rupp, B; Stefan, M; Maierhofer, T; Höfler, G; Guelly, C; Otte, M;
KRAS2 mutation analysis in serum samples surrogates tumour tissue
7th International Symposium on Minimal Residual Cancer; SEP 16-19, 2009; Athens, Greece. 2009.
[Poster]
FullText
Ladinek, V; Zloklikovits, S; Stanzer, S; Augustin, T; Janesch, B; Bauernhofer, T; Samonigg, H; Andritsch, E
The Influence of an Educational Intervention Program on Patients with Early Breast Cancer on Depression and Anxiety.
Abstract book of the 11 th IPOS World Congress of Psycho-Oncology published in
Psycho-Oncology2009; 18 (Suppl. 2): S1-S330.-11th IPOS World Congress of Psycho-Oncology; JUNE 23-25, 2009; Vienna, AUSTRIA. (ISBN: DOI: 10.1002/pon.159 )
Doi: 10.1002/pon.159
[Poster]
FullText
FullText_MUG
Loibner, H; Janzek, E; Peball, B; Schaefer, R; Schustet, M; Bauernhofer, T; Samonigg, H
Elevated Angiotensin II Levels in Plasma and Malignant Effusions of Cancer Patients: Recombinant Human ACE2 as Novel Biological Cancer Therapy
J IMMUNOTHER. 2009; 32(9):952-952.
[Poster]
Web of Science
Pichler, M; Balic M; Stadelmeyer, E; Ausch, C; Wild, M; Guelly, C; Bauernhofer, T; Samonigg, H; Dandachi, N
Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors
joint ZMF & Doctorial Day ; NOV 4-5, 2009; Graz, AUSTRIA. 2009.
[Oral Communication]
Pichler, M; Balic, M; Stadelmeyer, E; Ausch, C; Wild, M; Gülly C; Bauernhofer, T; Samonigg, H; Hoefler, G; Dandachi, N;
Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumours.
Frühjahrstagung 2009 der Österreichischen Gessellschaft für Hmatologie und Onkologie (ÖGHO); APR 16-18, 2009; Salzburg. 2009.
[Oral Communication]
Pichler, M; Samonigg, H; Bauernhofer, T;
Rhabdomyolysis as a complication of trabectedin (Yondelis) treatment in metastatic leiomyosarcoma: a case report.
Frühjahrstagung 2009 der Österreichischen gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 16-18, 2009; Salzburg, AUSTRIA. 2009.
[Poster]
Pöschl, EM; Wehr, E; Schweighofer, N; Pock, H; Eichinger, M; Bauernhofer, T; Obermayer-Pietsch, B
Bone serum marker characteristcs in women with and without breast cancer-Basline data.
joint ZMF & Doctorial Day ; NOV 4-5, 2009; Graz, AUSTRIA. 2009.
[Poster]
Pöschl, EM; Wehr, E; Schweighofer, N; Pock, H; Eichinger, M; Stanzer, S; Bauernhofer, T; Obermayer-Pietsch, B
Vitamin D und Knochenstoffwechselmarker bei Mammacarcinompatientinnen onkologische Serumbank und neueste osteo-endokrinologische Forschung
Ärzteverein Steiermark; 3.12.2009; Graz, Austria. 2009.
[Oral Communication]
Poschl, EM; Wehr, E; Schweighofer, N; Pock, T; Bauernhofer, T; Obermayer-Pietsch, B
Bone metabolism markers in breast cancer-patients with and without bone metastases - Baseline data
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A19-A19.-ÖGIM; Linz, AUSTRIA.
[Poster]
Web of Science
Pöschl, EM; Wehr, E; Schweighofer, N; Pock, T; Bauernhofer, T; Obermayer-Pietsch, B
Bone metabolism markers in breast cancer- patients with and without bone metastases- Baseline data.
WIEN KLIN WOCHENSCHR. 2009
. 2009; 121(15-16):A19-A19.-39. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; 17.-19. September, 2009; Wien.
[Poster]
Stanzer, S; Janesch, B; Andritsch, E; Ladinek, V; Zloklikovits, S; Augustin, T; Halm, M; Wagner, P; Samonigg, H; Bauernhofer, T;
Influence of Psychosocial Intervention on T Cell Subpopulations in Patients with Early Breast Cancer
Abstract Book of the 11th World Congress of Psycho-Oncology published in Psycho-Oncology2009; 18 (Suppl. 2): S1-S330.-IPOS 11th World Congress of Psycho-Oncology; JUN 23-25, 2009; Vienna, AUSTRIA. (ISBN: DOI: 10.1002/pon.159 )
Doi: 10.1002/pon.159
[Poster]
FullText
FullText_MUG
Stanzer, S; Janesch, B; Resel, M; Augustin, T; Samonigg, H; Bauernhofer, T
Relationship of oxidative stress products to the higher onset of spontaneous apoptosis of NK cell subsets in patients with metastatic epithelial cancer.
joint ZMF & Doctorial Day ; NOV 4-5 2009; Graz, AUSTRIA. 2009.
[Poster]
Stanzer, S; Janesch, B; Resel, M; Augustin, T; Samonigg, H; Bauernhofer, T
Relationship of oxidative stress products to the higher onset of spontaneous apoptosis of NK cell subsets in patients with metastatic epithelial cancer
5th Internation Symposium of Cellular Therapy; March 19-20 2009 ; Nürnberg, GERMANY. 2009.
[Poster]
Steiner, W; Sauer, S; Bauernhofer, T; Müller, H; Zatloukal, K
Interactive Patient Records
Joint ZMF and doctoral day, Medical University Graz; 2009; Graz. 2009.
[Poster]
Wagner, V; Gorischek, A; Stadelmeyer, E; Bauernhofer, T; Schreibmayer, W
Characterization Of Girk1 In Different Breast Cancer Cell Lines
Biophysical Journal, Volume 96, Issue 3, Supplement 1, February 2009, Page 465a
2009; 96(3):465a-465a.-53rd Annual Meeting of the Biophysical Society; FEB 28- MAR 4; Boston.
[Poster]
Wagner, V; Gorischek, A; Stadelmeyer, E; DeVaney, T; Schreibmayer, W; Bauernhofer, T
Expression and characterization of G-protein activated potassium channel splice variants.
joint ZMF & Doctorial Day ; NOV 4-5, 2009; Graz, AUSTRIA. 2009.
[Poster]
Andritsch, E; Zloklikovits, S; Ladinek, V; Stanzer, S; Janesch, B; Augustin,T; Samonigg, H; Bauernhofer, T;
Significant Improvements of psychological parameters by an educational intervention program for patients with early breast cancer.
J Clin Oncol 2008; 26(7s):A9591--44th Annual Meeting of the American Society of Clinical Oncology; May 30-June 3,; Chicago, IL, USA.
[Poster]
Andritsch, E; Ladinek, V; Zloklikovits, S; Janesch, B; Augustin, T; Samonigg, H; Bauernhofer, T;
Significant improvements of psychosocial parameters by an educational intervention program for patients with early breast cancer
ZMF Day; NOV 12 ; Graz. 2008.
[Oral Communication]
Bauernhofer, T;
Medikamentöse Tumortherapie bei Brustkrebs
Gemeinsame Jahrestagung der DGHO, ÖGHO, SGH, SGMO; OCT 10-14; Vienna. 2008.
[Oral Communication]
Fürtinger, S; Niesner, B; Gorischeck, A; DeVaney, T; Schreibmayer, W; Bauernhofer, T
INFLUENCE OF STABLE EXPRESSION OF EITHER THE GIRK1 OR THE GIRK4
PROTEIN ON VITAL PARAMETERS OF A BREAST CANCER CELL LINE
ZMF Day 2008; NOV 12, 2008; Graz. 2008.
[Poster]
Fürtinger, S; Niesner,B;Gorischek,A;DeVaney,T;Schreibmayer,W;Bauernhofer,T;
Influence of stable expression of either the GIRK1 or the GIRK4 protein on vital parameters of a breast cancer cell line
Trilateral Symposium of Physiology; SEP 18-19, 2008; Graz, AUSTRIA. 2008.
[Poster]
Hofmann, G; Dandachi, N; Balic, M; Schippinger, W; Samonigg, H; Regitnig, P; Bauernhofer, T
Soluble E-Cadherin and ist prognostic impact on response to neoadjuvant anthracycline-based chemotherapy in breast cancer patients.
Onkologie2008; 31 (suppl 4): 161-162.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 10-14, 2008; Vienna, AUSTRIA.
[Oral Communication]
Stanzer, S; Dandachi, N; Balic, M; Bauernhofer, T; Samonigg, H
The role of NKG2D expression and soluble MICA and MICB in the higher onset of apoptosis of NK cell subsets in patients with epithelial cancer
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A46-A46.
[Poster]
Web of Science
Wagner, V; Gorischek,A;Stadelmeyer,E;Bauernhofer,T;Schreibmayer,W
G-protein activated potassium channel splice variants and functional ion channels in breast cancer cell lines
ZMF Day 2008.
; NOV 12, 2008; Graz, AUSTRIA. 2008.
[Poster]
Wagner, V; Gorischek,A;Stadelmeyer,E;Bauernhofer,T;Schreibmayer,W;
G-protein activated potassium channel splice variants and functional ion channels in breast cancer cell lines
Trilateral SYmposium of Physiology; SEP 18-19, 2008; Graz, AUSTRIA. 2008.
[Poster]
Bauernhofer,T; Schippinger,W; Weitzer,W; Stöger, H; Samonigg,H;
Neoadjuvant therapy with liposomal doxorubicin in combination with docetaxel and trastuzumab in patients with locally advanced her2/neu positive breast cancer
Wiener Medizinische Wochenschrift2007; 157(121):9-9.-Frühjahrestagung 2007
der Österreichischen Gesellschaft für Hämatolgie und Onkologie (ÖGHO)
und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich (AHOP)
; APR 12-14, 2007; Vienna, Austria.
[Oral Communication]
Leithner, A; Bauernhofer, T; Maurer-Ertl, W; Spuller, E; Bodo, K; Windhager, R
Drittes primäres Osteosarkom in 22 Jahren.
Abstractband 29. ÖGO; 169:P094.2007; -29. Jahrestagung ÖGO; JUN 14-16, 2007; Vienna, AUSTRIA.
[Poster]
Pichler, M; Hoefler, G; Maderbacher, M; Gülly, C; Bauernhofer, T; Samonigg, H; Dandachi, N
Comparison of High Resolution Melting Analysis, Denaturing High Pressure Liquid Chromatography and DNA Sequencing for detection of Mutations in human colorectal tumor samples
2nd Gene Expression Symposiom; Oct 2007; Graz, Austria. 2007.
[Poster]
Pichler, M; Tockner, S; Bauernhofer, T; Samonigg, H; Dandachi, N
Comparison of real-time PCR instruments for the detection of melanoma cell markers
Clinical Chemistry and Laboratory Medicine2007; -Gemeinsamer Kongress der
Österreichischen Gesellschaft
für Laboratoriumsmedizin und Klinische Chemie (ÖGLMKC) und der
Deutschen Vereinten Gesellschaft
für Klinische Chemie und Laboratoriumsmedizin (DGKL); SEP 19-22, 2007; Vienna, Austria.
[Poster]
Riederer, M; Janesch, B; Dandachi, N; Resel, M; Tockner, S; Gorischeck, A; Schreibmayer, W; Bauernhofer, T;
Expression and regulation of Gproteinactivated inwardly rectifying K+ (GIRK) channels in different breast cancer cell lines
ZMF Day; NOV 11, 2007; Graz, AUSTRIA. 2007.
[Oral Communication]
Schippinger, W; Dandachi, N; Regitnig, P; Hofmann, G; Balic, M; Schug, A; Bauernhofer, T; Samonigg, H
Influence of neoadjuvant chemotherapy on the HER-2/neu status of breast cancer tissue.
Supplement 121; 157(25):28-28.-Frühjahrstagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 12-14, 2007; Vienna, AUSTRIA .
[Poster]
Schippinger, W; Holub, R; Dandachi, N; Bauernhofer, T
Frequency of febrile neutropenia in patients treated with taxane/epirubicine and colony-stimulating growth factors for breast cancer: comparison of filgrastim/lenograstim with pegfilgrastim
BREAST CANCER RES. 2007; 9(1):
Doi: 10.1186/bcr1722
[Poster]
Web of Science
FullText
FullText_MUG
Schippinger, W; Lileg, B; Ploner, F; Weitzer, W; Bauemhofer, T; Samonigg, H
Neoadjuvant chemotherapy with non-pegylated liposomal doxorubicin, docetaxel and trastuzumab in HER-2/neu overexpressing breast cancer
ANN ONCOL. 2007; 18: 166-166.
[Poster]
Web of Science
Schippinger,W; Regitnig,P; Dandachi,N; Wernecke,KD; Bauernhofer,T; Samonigg,H;Moinfar, F;
Examination of the prognostic significance of androgen receptor expression in metastatic breast cancer
Wiener Medizinische Wochenschrift2007; 157(121):8-8.-Frühjahrestagung 2007
der Österreichischen Gesellschaft für Hämatolgie und Onkologie (ÖGHO)
und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich (AHOP)
; APR 12-14, 2007; Vienna, Austria.
[Oral Communication]
Stanzer, S; Dandachi, N; Balic, M; Janesch, B; Resel, M; Samonigg, H; Bauernhofer, T
Higher turnover of NK cells and NK cell subpopulations in patients with metastatic epithelial cancer
World Immune Regulation Meeting; APR 11-15, 2007 ; Davos, Switzerland. 2007.
[Poster]
Andritsch, E; Bauernhofer, T
Psychoneuroimmunology: theory and practice- challanges and limitation in conducting clinical trials in this field
Psycho-Oncology 4th International Conference; MAR 15-17, 2006; Graz, AUSTRIA. 2006.
[Oral Communication]
Andritsch, E; Dietmaier, G; Bauernhofer, T; Samonigg, H
The influence of an artistic ward design on the wellbeing of cancer patients at the Division of Oncology at the Medical University of Graz
PSYCHO-ONCOL. 2006; 15(2):S71-S71.-8th World Congress of Psycho-Oncology; OCT 16-21, 2006; Ferrara-Venice, Italy.
[Poster]
Web of Science
Andritsch, E; Dietmaier, G; Zloklikovits, S; Ladinek, V; Samonigg, H
Psychologischer Distress und Coping bei Brustkrebspatientinnen: Einfluss von Alter, Partnerbeziehung und Aktivität (Beruf, Freizeitverhalten).
-7. Tagung der Österreichischen Gesellschaft für Psychologie; APR 28-30, 2006; Klagenfurt, AUSTRIA.
[Oral Communication]
Andritsch, E; Ladinek, V; Zloklikovits, S; Stanzer, S; Bauernhofer, T
Identifying symptom burden and distress of cancer patients with chemotherapy: A pilot study for an Austrian sample
PSYCHO-ONCOL. ; 15(2):S158-S159.
[Poster]
Web of Science
Andritsch, E; Ladinek, V; Zloklikovits, S; Stanzer, S; Bauernhofer, T
Psycho-neuro-immunology: Influence of psychosocial intervention on T and NK cell subsets in patients with breast cancer
PSYCHO-ONCOL. ; 15(2):S131-S131.-8th world congress of psycho-oncology; OCT 16-21, 2006; Ferrara-Venice, Italy.
[Poster]
Web of Science
Bauernhofer, T; Andritsch, A; Ladinek, V; Zloklikovits, S; Stanzer, S; Janesch, B; Halm, M; Dandachi, N; Samonigg, H
Influence of Psychosocial Intervention on T and NK Cell Subsets in Patients with Breast Cancer
ZMF Tag; OCT 24, 2006; Graz, AUSTRIA. 2006.
[Poster]
Bauernhofer, T; Samonigg, H; Regitnik, P; Lileg, B; Weizer, W; Waxenecker, G; Kainer, M; Wiederkum, S; Loibner, H; Kircheis, R
A phase I/II, open label trial of Lewis Y specific monoclonal antibody IGN311 to evaluate safety and efficacy in patients with malignant effusion.
J CLIN ONCOL. 24(18):111S-111S.-Asco-Meetung; 2.-6. Juni 2006; Atlanta/ Georgia, USA.
[Poster]
Web of Science
Heller, A; Bauernhofer, T; N, N
An artist, an oncologist, a patient - a dialogue
PSYCHO-ONCOL. 2006; 15(2):S71-S72.-8th World Congress of Psych-Oncology; OCT 16-21, 2006; Ferrara-Venice, Italy.
[Oral Communication]
Web of Science
Leithner, A; Ertl, W; Windhager, R; Bauernhofer, T; Spuller, E; Bodo, K
Third primary osteosarcoma in a 22-year interval.
J N N Blokhin Russian Cancer Res Center RAMS 2006;S1:27; -19th EMSOS Meeting; MAY 24-26, 2006; Moscow, Russia.
[Poster]
Liegl, B; Leithner, A; Bauernhofer, T; Windhager, R; Gülly, C; Regauer, S; Beham, A
Analysis of PDGF and PDGFR and gene mutations in desmoid tumors: Potential therapeutic options.
Abstract 018; -6th Central European Orthopaedic Congress; MAY-JUN 31-3, 2006; Graz, AUSTRIA.
[Oral Communication]
Liegl, B; Regauer, S; Beham, A; Windhager, R; Leithner, A; Bauernhofer, T; Gülly, C
Desmoid tumors: Analysis of PDGF, PDGFR and gene mutations.
J N N Blokhin Russian Cancer Res Center RAMS 2006;S1:27; -19th EMSOS Meeting; MAY 24-26, 2006; Moscow, Russia.
[Poster]
Loibner, H; Bauernhofer, T; Samonigg, H; Regitnig, P; Weitzer, W; Lileg, B; Waxenecker, G; Kainer, M; Wiederkum, S; Schuster, M; Kircheis, R
A phase I/II, open label trial with the Lewis Y specific humanized monoclonal antibody IGN311 in patients with malignant effusions
J IMMUNOTHER. 29(6):634-634.-Meeting Society of Immunotherapy, 21st annual meeting; 26.-29. Oktober 2006; Los Angeles, USA.
[Poster]
Web of Science
Raml, R; Goessler, W; Traar, P; Bauernhofer, T; Francesconi, KA;
Individual variability in human metabolism of arsenosugar.
2. ASCA-JunganalytikerInnen Forum; OCT 9-10, 2006; Garz, Austria. 2006.
[Oral Communication]
Raml, R; Goessler, W; Traar, P; Bauernhofer, T; Francesconi, KA;
Individual variability in human metabolism of arsenosugar.
6th International Symposium on Speciation of Elements in Biological, Environmental, and Toxicological Sciences (ISSEBETS); JUN 21-25, 2006; Bialowieza, Poland. 2006.
[Poster]
Riederer, M; Richtig, E; Dandachi, N; Resel, M; Tockner, S; Gerger, A; Kerl, H; Samonigg, H; Bauernhofer, T
Quantitative detection of circulating tumor cells in peripheral blood of melanoma patients using multimarker real-time PCR and immunomagnetic cell sorting: A preclinical evaluation
ZMF Day ; 24.11.06; Graz, Austria. 2006.
[Poster]
Samonigg, H; Andritsch, E; Dietmaier, G; Bauernhofer, T; Andritsch, H; Zloklikovits, S; Kasparek, AK; Stoeger, H; Schaberl-Moser, R; Ploner, F
Healing by Design: the Influence of an Artistic Design on the Wellbeing of Cancer Patients-- a 10 Years Follow Up.
Journal of Clinical Oncology. 2006 ASCO Annual Meeting Proceedings Part I. (June 20 Supplement); 24(18S):-2006 ASCO Annual Meeting; JUNE 2-6, 2006; Atlanta, USA.
[Poster]
Stanzer, S; Dandachi, N; Balic, M; Resel, M; Janesch, B; Samonigg, H; Bauernhofer, T
Increase in the Number and Resistance to Programmed Cell Death of CD4+CD25+high regulatory T cells in Patients with Metastatic Epithelial Cancer.
ZMF Tag; OCT 24, 2006; Graz, AUSTRIA. 2006.
[Poster]
Weitzer, W; Bauernhofer, T; Stoeger, H; Langsenlehner, U; Lax, S; Samonigg, H
High-grade endometrial stroma sarcoma treated with aromatase inhibitor letrozole
Wiener Medizinische Wochenschrift. 156(25):9-9.-Frühjahrstagung 2006 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 27-29, 2006; Wels, AUSTRIA.
[Poster]
Hofmann, G; Dandachi, N; Balic, M; Schippinger, W; Resel, M; Wernecke, KD; Samonigg, H; Bauernhofer,T;
Serum levels of soluble E-cadherin as possible predictive and prognostic marker in female breast cancer patients undergoing neoadjuvant therapy.
Wiener Medizinische Wochenschrift2005; 155(117):2-3.-Frühjahrstagung 2005 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO)und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich
; APR 28-30, 2005; Graz, Austria.
[Oral Communication]
Hofmann, G; Dandachi, N; Balic, M; Schippinger, W; Wernecke, KD; Samonigg, H; Bauernhofer, T
Quantitative measurement of soluble E-cadherin in sera of breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy and its predictive and prognostic value.
J CLIN ONCOL 2005 23: 70S-70S.
Web of Science
Lileg, B; Bauernhofer,T; Popper, H; Ranner,G; Samonigg, H;
C-kit expression of an extra-abdominal desmoid tumor and response to imatinib mesylate therapy
Wiener Medizinische Wochenschrift2005; 155(117):16-17.-
Frühjahrstagung 2005 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO) und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich ; APR 28-30, 2005; Graz, Austria.
[Poster]
Samonigg, H; Himmler, G; Gnant, M; Gastl, G; Loibner, H; Possinger, K; Bauernhofer, T; Dandachi, N; Balic, M; Steger, G; Obwaller, A
A multicenter phase II, open-label trial of multiple doses of cancer vaccine candidate IGN101 to evaluate efficacy against disseminated tumor cells in blood.
J CLIN ONCOL 2005 23: 180S-180S.
Web of Science
Schippinger,W; Regitnig,P; Moinfar,F; Dandachi,N; Bauernhofer,T; Wernecke,WD; Samonigg,H;
Häufigkeit der Expression von Androgen-Rezeptoren beim Mammakarzinom.
Wiener Medizinische Wochenschrift2005; 155(117):11-11.-Frühjahrstagung 2005 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO) und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich; APR 28-30, 2005; Graz, Austria.
[Poster]
Stanzer, S; Dandachi, N; Resel, M; Balic, M; Samonigg, H; Bauernhofer, T;
High TurnOver of CD4+CD25+ T cell Subpupulation in patients with Metastatic epithelial cancer
Wiener Medizinische Wochenschrift2005; 155(117):19-20.-Frühjahrstagung 2005 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO) und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich; APR 28-30, 2005; Graz, Austria.
[Poster]
Weitzer, W; Regauer,S; Schöllnast, H; Eder,T; Vrecl, R; Bauernhofer,T; Samonigg, H;
Partial remission of a metastasized epitheloid sarcoma with anti-estrogen therapy with tamoxifen A case report
Wiener Medizinische Wochenschrift2005; 155(117):20-21.-Frühjahrstagung 2005 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO) und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich; APR 28-30, 2005; Graz, Austria.
[Poster]
Ludwig, H; Zojer, N; Linkesch, W; Kahls, P; Krieger, O; Greinix, HT; Hinterberger, W; Pittermann, E; Bauernhofer, T; Gastl, G
Results of autologous transplantation for multiple myeloma (MM) in Austria. An analysis based on data from the Austrian Stem Cell Transplantation (ASCT) Registry
J CLIN ONCOL 2004 22: 596S-596S.
Web of Science
Weitzer, W; Bauernhofer, T; Eder, T; Langsenlehner, U; Samonigg, H
Corticosteroidtherapie bei retroperitonealer Fibrose- ein Fallbericht
Kongressband des 50. Ausseer Symposium 2004; -50. Ausseer Symposium; MAY 6-9, 2004; Bad Aussee, AUSTRIA.
[Poster]
Balic, M; Bauernhofer, T; Hofmann, G; Dandachi, N; Himmler, G; Obwaller, A; Oberkleiner, P; Grunt, S; Loibner, H; Samonigg, H
Evaluation of epithelial cell enumeration methods to detect tumor cells of cancer patients
Proc Am Soc Clin Oncol 2003; 22:(abstr 3607): -Annual Meeting of the American Society of Clincal Oncology (ASCO); MAY 31 - JUN 3, 2003; Chicago, Ill., USA.
[Poster]
Bauernhofer,T; Kuss, I; Stanson, J; Vonderhaar, BK; Whiteside, TL;
Interleukin-2 driven differential expression of the human prolactin receptor in natural killer cells.
Proc Amer Assoc Cancer Res 2003;2003; 44: Abstr#5643: -94th Annual Meeting of the American Association for Cancer Research(AACR); JUL 11-14, 2003; Washington DC, USA.
[Poster]
Obwaller, A; Balic, M; van der Kooi, A; Dandachi, N; Himmler, G; Mudde, GC; Peball, B; Grunt, S; Oberkleiner, P; Doyle, GV; Terstappen, LWMM; Bauernhofer, T; Samonigg, H; Loibner, H
Comparative analysis of three different methods for the detection of disseminated tumor cells
J IMMUNOTHER 2003 26: S49-S50.
Web of Science
Samonigg, H; Hofmann, G; Bauernhofer, T; Balic, M; Stöger, H; Groiss, F; Himmler, G; Schuster, M; Rosenkaimer, F; Loibner, H
Phase if trial to explore the influence of concomitant chemotherapies on the immunogenicity of the cancer vaccine IGN101 in patients with epithelial cancers
J IMMUNOTHER 2003 26: S14-S14.
Web of Science
Samonigg, H; Hofmann, G; Bauernhofer, T; Balic,M; Stoeger, H; Himmler, G; Schuster, M; Rosenkaimer, F; Groiss,F; Loibner, H;
Phase II trial to explore the influence of concomitant chemotherapy on the immunogenicity of the cancer vaccine IGN101 in patients with epithelial cancers
Proc Am Soc Clin Oncol 2003; 22:(abstr 683): -Annual Meeting of the American Society of Clinical Oncology (ASCO); May 31-JUN 3, 2003; Chicago, Ill., USA.
[Poster]
Schippinger, W; Bauernhofer, T; Regitnig, P; Ploner, F; Krippl, P; Hofmann, G; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu dynamics in metastatic breast cancer as an independent prognostic factor.
BREAST CANCER RES TREAT 2003 82: S123-S123.
Web of Science
Schippinger, W; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu levels correlate with time to progression in therapy of metastatic breast cancer.
BREAST CANCER RES TREAT 2002 76: S104-S104.
Web of Science
Hubmer, M; Koch, H; Haas, F; Gabor, S; Bauernhofer, Th; Scharnagl, E
Radikale Resektion und Defektdeckung beim lokal fortgeschrittenen Mammacarzinom (Lokalrezidiv) mit Thoraxwandinfiltration. Ein palliativer Therapieansatz? Eine Indikation für die Mikrochirurgie?
Abstractband der 31. Jahrestagung der Vereinigung der Deutschen Plastischen Chirurgen, European Joint Meeting of Plastic, REconstructive and Aesthetic Surgeons with International Attendance2000; -31. Jahrestagung der Vereinigung der Deutschen Plastischen Chirurgen, European Joint Meeting of Plastic, REconstructive and Aesthetic Surgeons with International Attendance; SEP 13-19, 2000; Magdeburg, GERMANY.
[Oral Communication]
Bauernhofer, T; Schmid, M; Resel, M; Gilli, R; Halwachs, G; Lanzer, G; Wilders-Truschnig, M; Samonigg, H
Detection of minimal residual disease in bone marrow (BM) peripheral blood (PB) and apheresis products (AP) in metastatic breast cancer patients receiving sequential dose intensive chemotherapy with PBPC support.
BONE MARROW TRANSPLANT 1999 23: S145-S145.
Web of Science
Bauernhofer, T; Schmid, M; Stoeger, H; Kasparek, AK; Ploner, F; Kuss, I; Gilli, R; Lanzer, H; Samonigg, H
Sequential dose intensive chemotherapy with cyclophosphamide and carboplatin (CC) with peripheral blood progenitor cell (PBPC) support in metastatic breast cancer patients.
BONE MARROW TRANSPLANT 1999 23: S37-S37.
Web of Science
Hubmer, M; Haas, F; Bauernhofer, T; Koch, H; Gabor, S; Scharnagl, E
Problemdefekte der Thoraxwand beim fortgeschrittenen Mammacarzinom (Lokalrezidiv)-Management und Therapie
Acta Chirurgica Austriaca1999; -Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Plastische Ästhetische und Rekonstruktive Chirurgie (37. Jahrestagung) und der Österreichischen Gesellschaft für Senologie (16. Jahrestagung); OKT 14-16, 1999; Baden, AUSTRIA.
[Oral Communication]
Samonigg, H; Kuss, I; Bauernhofer, T; Andritsch, E
The influence of an artistic design at an oncological ward on the patients' mood
PSYCHO-ONCOL 1999 8: 41-41.
Web of Science
Schmid, M; Bauernhofer, T; Resel, M; Ploner, F; Schippinger, W; Gilli, R; Lanzer, G; Truschnig-Wilders, M; Samonigg, H
High-dose chemotherapy with peripheral blood stem cell support for high risk breast cancer.
BONE MARROW TRANSPLANT 1999 23: S42-S42.
Web of Science
Derstvenscheg, E; Stöger, H; Stranzl, H; Bauernhofer, T; Ploner, F; Samonigg, H
Das männl. Mammakarzinom- ein Bericht über 43 Patienten
Acta Chirurgica Austriaca, 28 (125), 1996, p 131996; 28(125):13-13.-Senologiekongress; 17.-19. Oktober 1996; Graz, Österreich.
[Poster]
SAMONIGG, H; WILDERSTRUSCHNIG, M; KUSS, I; PLOT, R; STOGER, H; SCHMID, M; BAUERNHOFER, T; TIRAN, A; HAVELEC, L; LOIBNER, H
IMMUNIZATION WITH ANTIIDIOTYPE VACCINE SCV-106 PROLONGS SURVIVAL-TIME OF CANCER-PATIENTS WITH METASTATIC COLORECTAL-CANCER - A RANDOMIZED DOUBLE-BLIND CLINICAL-TRIAL
EUR J CANCER 1995 31A: 45-45.
Web of Science